Contract facts
FederalNo full NAICS 561320 intel page yet. Browse NAICS intelligence
INFECTIONIST PREVENTIONIST (1 FTE) is a federal award for Fa4887 56 Cons Cc held by Access Therapies Inc. Estimated value $862K ($466K obligated). Current period of performance ends Apr 25, 2024. Last award drew 7 bidders. Place of performance: LUKE AFB AZ.
Recompete timing
PublicCurrent PoP ended Apr 25, 2024 (848 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordAccess Therapies Inc — $32.6M obligated across 99 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract FA488719FA061?
FA488719FA061 (Infectionist preventionist (1 FTE) is a Fa4887 56 Cons Cc award with a potential value of $862K, currently held by Access Therapies Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded FA488719FA061?
Fa4887 56 Cons Cc awarded FA488719FA061 to Access Therapies Inc (potential $862K).
Who is the incumbent on FA488719FA061?
Access Therapies Inc is the incumbent with $32.6M across 99 related awards in SCOUT’s public footprint. The current period of performance ends Apr 25, 2024.
When does Access Therapies Inc’s FA488719FA061 come up for recompete?
SCOUT tracks a period-of-performance end of Apr 25, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.